BackEuropean Biotech Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview
European Biotech Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)

European Biotech Acquisition - Units (1 Ord Share Class A & 1/3 War) P/E Ratio

Valuation check: EBACU's P/E ratio is 41.44, above the sector sector average of 24.91.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

41.44

P/E Ratio

41.44

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

European Biotech Acquisition - Units (1 Ord Share Class A & 1/3 War) (EBACU) FAQ

As of the most recent data, EBACU shows a P/E ratio of 41.44. That is above the sector sector average of 24.91. Scroll down for historical charts and peer comparison views.

The its sector sector average P/E ratio is about 24.91. European Biotech Acquisition - Units (1 Ord Share Class A & 1/3 War) is at 41.44, which is higher that average. That is roughly 66.4% above the sector mean. Use the comparison chart on this page to see how EBACU stacks up against individual peers as well.

Investors watch EBACU's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. European Biotech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s latest reading is 41.44. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has European Biotech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 41.44) with ownership activity and broader fundamentals.